Research ArticleHIV

Delayed differentiation of potent effector CD8+ T cells reducing viremia and reservoir seeding in acute HIV infection

See allHide authors and affiliations

Science Translational Medicine  15 Feb 2017:
Vol. 9, Issue 377, eaag1809
DOI: 10.1126/scitranslmed.aag1809

Peak HIV viremia pushes CD8+ T cells

Aside from CD4+ T cell death, the immune system in chronically infected HIV patients is dysfunctional, including the inability of CD8+ T cells to control the virus. Animal studies with simian immunodeficiency virus have suggested that early CD8+ T cell responses may be capable of reducing viral burden, but getting access to patient samples at the earliest stage of infection is challenging. Takata et al. examined a large cohort of acutely infected patients that were given antiretroviral therapy (ART) upon enrollment in the study to evaluate T cell activation and HIV viral load over time, allowing them to parse out immune function (or dysfunction) based on acute stages of infection. They saw that CD8+ T cell responses were a little slow to ramp up but that activated CD8+ T cells present after initiation of ART could reduce the magnitude of the viral reservoir. These findings confirm that targeting CD8+ T cells at the early stage of infection could lead to viral eradication.


CD8+ T cells play a critical role in controlling HIV viremia and could be important in reducing HIV-infected cells in approaches to eradicate HIV. The simian immunodeficiency virus model provided the proof of concept for a CD8+ T cell–mediated reservoir clearance but showed conflicting evidence on the role of these cells to eliminate HIV-infected cells. In humans, HIV-specific CD8+ T cell responses have not been associated with a reduction of the HIV-infected cell pool in vivo. We studied HIV-specific CD8+ T cells in the RV254 cohort of individuals initiating ART in the earliest stages of acute HIV infection (AHI). We showed that the HIV-specific CD8+ T cells generated as early as AHI stages 1 and 2 before peak viremia are delayed in expanding and acquiring effector functions but are endowed with higher memory potential. In contrast, the fully differentiated HIV-specific CD8+ T cells at peak viremia in AHI stage 3 were more prone to apoptosis but were associated with a steeper viral load decrease after ART initiation. Their capacity to persist in vivo after ART initiation correlated with a lower HIV DNA reservoir. These findings demonstrate that HIV-specific CD8+ T cell magnitude and differentiation are delayed in the earliest stages of infection. These results also demonstrate that potent HIV-specific CD8+ T cells contribute to the reduction of the pool of HIV-producing cells and the HIV reservoir seeding in vivo and provide the rationale to design interventions aiming at inducing these potent responses to cure HIV infection.

View Full Text

Stay Connected to Science Translational Medicine